Evidence map›Paper›PMID 26097735›Full record

ReviewF1000prime reports2015

Advances in understanding Giardia: determinants and mechanisms of chronic sequelae.

Luther A Bartelt, R Balfour Sartor

Open access · diamondAbstract readReview
In one paragraph

Review in F1000prime reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 151 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. T cell exhaustion inParasite epidemiology and control · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Influence of the ProtozoanInternational journal of molecular sciences · 2024
    Review
  17. Current Understanding ofCurrent tropical medicine reports · 2024
    Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Luther A BarteltDivision of Infectious Diseases and International Health, University of Virginia Box 801340, Charlottesville, VA 22908 USA.
R Balfour SartorDivision of Gastroenterology, Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill Campus Box 7032, Chapel Hill, NC 27599-7032 USA.
University of North Carolina at Chapel Hill · USUniversity of Virginia · US

Funding

Cytokine signaling and IEC restitution in enteropathy: the Giardia paradigmK08AI108730 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARTELT, LUTHER A · 2014 to 2018
$938k
NIAID NIH HHS K08 AI108730
6 · The paper itself

Abstract

Giardia lamblia is a flagellated protozoan that is the most common cause of intestinal parasitic infection in children living in resource-limited settings. The pathogenicity of Giardia has been debated since the parasite was first identified, and clinical outcomes vary across studies. Among recent perplexing findings are diametrically opposed associations between Giardia and acute versus persistent diarrhea and a poorly understood potential for long-term sequelae, including impaired child growth and cognitive development. The mechanisms driving these protean clinical outcomes remain elusive, but recent advances suggest that variability in Giardia strains, host nutritional status, the composition of microbiota, co-infecting enteropathogens, host genetically determined mucosal immune responses, and immune modulation by Giardia are all relevant factors influencing disease manifestations after Giardia infection.

Identifiers

PMID26097735
PMCPMC4447054
OpenAlexW2418854787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.